ASH 2018: Education program session
Chaired by Professor Jane Apperley with Professor Tim Hughes and Professor Charles Craddock
Held on 1–4 December, 2018 at the San Diego Convention Center, San Diego, California, USA
This education session was chaired by Professor Jane Apperley, from Imperial College London in the UK, and discussed the optimal management of patients with chronic myeloid leukaemia at diagnosis and through disease progression. Using case studies, Apperley and her co-presenters Professor Tim Hughes and Professor Charles Craddock reviewed tyrosine kinase inhibitor treatment decisions that are made in the clinic and when allogeneic stem cell transplantation might be considered.